BioInformatiCo's Leova ranks second in global AI challenge
Leova, a South African AI platform from BioInformatiCo, took second place in an international competition focused on automating checks of clinical trial databases. The tool also helps researchers get medical trials for drugs and vaccines ready.
By Standard Topic. AI-generated from the reporting listed under Coverage. Published . Updated .
This story is no longer being updated. It reflects reporting up to .
What happened
BioInformatiCo's Leova platform, a South African AI tool, placed second in a global AI challenge. The challenge centered on automating the testing of clinical trial databases. The platform also helps researchers prepare clinical trials for medicines and vaccines.
Why it matters
The result brings global recognition to the South African platform.
Timeline
- Oct 19, 1:02 PM ET: A South African AI platform secured global recognition for a tool that helps researchers prepare clinical trials for medicines and vaccines.
- Oct 20, 2:25 AM ET: Leova, BioInformatiCo's platform, placed second in a global AI challenge for automating clinical trial database testing.
Coverage
- SA AI platform earns global recognition (itweb.co.za)
- South African AI platform wins global recognition for a unique Digital clinical preparations tool (tanzaniatimes.net)
More from Health
- Hackensack Meridian Health and Hunterdon Health agree to merge
- Roche signs $15 billion antibody-drug conjugate deal with Hansoh
- Putin's daughter predicts aging breakthroughs within 10 to 20 years
- Cardiologists urged to prescribe exercise for heart patients
- Pennsylvania measles outbreak tops 1,200 as CDC sends investigator
- AstraZeneca enlists Oracle to apply AI in drug trials